Private Wealth Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.46M |
| 2 |
Qualcomm
QCOM
|
+$2.39M |
| 3 |
Alibaba
BABA
|
+$2.37M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$2.35M |
| 5 |
Walt Disney
DIS
|
+$1.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$10.5M |
| 2 |
Bank of America
BAC
|
+$5.78M |
| 3 |
Chevron
CVX
|
+$3.88M |
| 4 |
Starbucks
SBUX
|
+$2.58M |
| 5 |
Boston Scientific
BSX
|
+$1.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 21.32% |
| 3 | Financials | 19.15% |
| 4 | Communication Services | 13.91% |
| 5 | Consumer Discretionary | 11.98% |
Similar funds
Private Wealth Partners's Q1 2020 Portfolio in Review
As of Q1 2020, Private Wealth Partners held 140 positions worth $593M, down 19% from $734M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Private Wealth Partners withdrew a net $29.1M in Q1 2020, closing 16 positions and reducing 59 holdings. Its most notable exit was DuPont de Nemours, an estimated $1.72M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Private Wealth Partners opened a new position in Vertex Pharmaceuticals worth $2.44M.
- Private Wealth Partners's largest Q1 2020 buy was Vertex Pharmaceuticals: 10,239 shares worth $2.44M.
- Private Wealth Partners added most to Microsoft in Q1 2020, an estimated $2.46M increase.
- Private Wealth Partners's biggest Q1 2020 reduction was Boeing, cutting an estimated $10.5M.
- Private Wealth Partners fully exited DuPont de Nemours in Q1 2020, selling an estimated $1.72M.
- Private Wealth Partners's ten largest holdings make up 51% of its $593M portfolio in Q1 2020.
- Private Wealth Partners opened 17 new positions and closed 16 in Q1 2020.
- Private Wealth Partners's portfolio value fell 19% quarter-over-quarter to $593M.
Based on Private Wealth Partners's 13F filing for Q1 2020, filed 24 Apr 2020.